COMMENTARY
Metallothioneins in Brain—The Role in Physiology and Pathology

https://doi.org/10.1006/taap.1996.8054Get rights and content

Abstract

A symposium on the role of brain metallothioneins (MTs) in physiology and pathology was held at the 1996 Annual Society of Toxicology Meeting in Anaheim, California. The objectives of this symposium were to: (1) review the physiologic function of MTs, (2) examine the distribution of brain MTs with particular emphasis on cell-specific localization (neurons vs neuroglia), (3) discuss MT gene responsiveness upon toxic insult with metals, and (4) discuss the potential role of MTs in the etiology of neurodegenerative disorders. Dr. Cherian discussed the biochemical properties of the MTs, emphasizing structural similarities and differences between the MTs. Dr. Klaassen addressed the expression and distribution of the MTs in brains with special reference to the cell-specific localization of MTs. Dr. Aschner provided data illustrating a potential role for MTs in attenuating the cytotoxicity caused by methylmercury (MeHg) in cultured neonatal astrocytes. Dr. Palmiter discussed the properties of MT-III and the increased sensitivity of MT-III knockout mice to kainate-induced seizures. Cerebral zinc metabolism, its relationship to MT homeostasis, and its pathogenic potential in Alzheimer's disease was addressed by Dr. Bush.

References (121)

  • M. Ebadi

    Metallothioneins and other zinc-binding proteins in brain

    Methods Enzymol.

    (1991)
  • M. Ebadi et al.

    Expression and regulation of brain metallothionein

    Neurochem. Int.

    (1995)
  • J.C. Erickson et al.

    Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein III (GIF)

    Brain Res.

    (1994)
  • C.J. Frederickson et al.

    Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: A histofluorescence study

    Brain Res.

    (1988)
  • C.J. Frederickson et al.

    Cyto-architectonic distribution of zinc in the hippocampus of man and the rat

    Brain Res.

    (1983)
  • G.G. Glenner et al.

    Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

    Biochem. Biophys. Res. Commun.

    (1984)
  • C. Hilbich et al.

    Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

    J. Mol. Biol.

    (1991)
  • C. Hilbich et al.

    Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptides

    J. Mol. Biol.

    (1992)
  • T. Itoh et al.

    Restraint stress-induced changes in endogenous zinc release from the rat hippocampus

    Brain Res.

    (1993)
  • E.M. Johnstone et al.

    Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis

    Mol. Brain Res.

    (1991)
  • P. Kille et al.

    Memories of metallothionein

    Biochim. Biophys. Acta

    (1994)
  • Y. Komiyama et al.

    Purification of factor XIa inhibitor from human platelets

    Thromb. Res.

    (1992)
  • J.S. Lazo et al.

    Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes

    J. Biol. Chem.

    (1995)
  • D.L. Miller et al.

    Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease

    Arch. Biochem. Biophys.

    (1993)
  • E.A. Milward et al.

    The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth

    Neuron

    (1992)
  • K. Nakajima et al.

    Immunochemical detection of metallothionein in brain

    Neurochem. Int.

    (1995)
  • R.M. O'Neal et al.

    Effect of zinc deficiency and restricted feeding on protein and ribonucleic acid metabolism of rat brain

    J. Nutr.

    (1970)
  • R.D. Palmiter

    Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient

    Toxicol. Appl. Pharmacol.

    (1995)
  • J. Perez-Clausell et al.

    Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study

    Brain Res.

    (1985)
  • C.J. Pike et al.

    In vitro aging of b-amyloid protein causes peptide aggregation and neurotoxicity

    Brain Res.

    (1991)
  • J.L. Price et al.

    The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

    Neurobiol. Aging

    (1991)
  • S.-J. Rhee et al.

    Metallothionein accumulation in CHO Cdr

    Chem. Biol. Interact.

    (1989)
  • S.B. Roberts et al.

    Non-amyloidogenic cleavage of the β-amyloid precursor protein by an integral membrane metalloendopeptidase

    J. Biol. Chem.

    (1994)
  • A.E. Roher et al.

    Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease

    J. Biol. Chem.

    (1993)
  • W. Schubert et al.

    Localization of bA4 precursor protein at central and peripheral synaptic sites

    Brain Res.

    (1991)
  • M. Aschner

    Methylmercury in astrocytes—What possible significance?

    NeuroToxicology

    (1996)
  • S.Y. Assaf et al.

    Release of endogenous Zn2+

    Nature

    (1984)
  • J.R. Backstrom et al.

    Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: Identification of calcium-dependent metalloproteinases from the hippocampus

    J. Neurochem.

    (1992)
  • M.A. Baeteman et al.

    Immunoreactive copper–zinc superoxide-dismutase (SOD-1) in mosaic trisomy 21 and normal subjects

    Acta Paediatr. Scand.

    (1984)
  • R.J. Baker et al.

    Platelet metal levels in normal subjects determined by atomic absorption spectrophotometry

    Thromb. Haemostasis

    (1978)
  • B. Bjorksten et al.

    Zinc and immune function in Down's syndrome

    Acta Paediatr. Scand.

    (1980)
  • A.I. Bush

    Aspects of the Pathophysiology and Pathogenesis of Alzheimer's Disease

    (1992)
  • A.I. Bush et al.

    Zinc and Alzheimer's disease

    Science

    (1995)
  • A.I. Bush et al.

    Rapid induction of Alzheimer Ab amyloid formation by zinc

    Science

    (1994)
  • A.I. Bush et al.

    An abnormality of plasma amyloid protein precursor in Alzheimer's disease

    Ann. Neurol.

    (1992)
  • D.W. Choi

    Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists

    Stroke

    (1990)
  • J. Chung et al.

    Metallothionein levels in liver and kidney of Canadians—A potential indicator of environmental exposure to cadmium

    Arch. Environ. Health.

    (1986)
  • J. Constantinidis

    Maladie d'Alzheimer et la théorie du zinc

    L'Encephale

    (1990)
  • T.P. Coogan et al.

    Enhanced metallothionein gene expression is associated with protection from cadmium-induced genotoxicity in cultured rat liver cells

    J. Toxicol. Environ. Health

    (1994)
  • F.M. Corrigan et al.

    Hippocampal tin, aluminum and zinc in Alzheimer's disease

    Biometals

    (1993)
  • Cited by (0)

    K. T. SuzukiN. KimuraI. Kimura, Eds.

    View full text